Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Market Commentary

Tech Rally Pauses as Nvidia Stumbles: Can the Nasdaq 100 Regain Momentum?

Robert Sasse by Robert Sasse
November 25, 2025
in Market Commentary, Nasdaq, Semiconductors, Tech & Software
0
NASDAQ 100 Stock
0
SHARES
67
VIEWS
Share on FacebookShare on Twitter

The Nasdaq 100’s impressive ascent has hit a temporary wall. Following a spectacular Monday session where the tech-heavy index surged 2.54 percent—a gain exceeding 600 points—early Tuesday trading indicates a breather is underway. The psychologically significant 25,000 level came within reach, but heavyweight Nvidia is now tempering the market’s enthusiasm. The critical question for investors is whether this represents a healthy consolidation or the setup for a bull trap.

Chip Giant’s Setback Dampens Sentiment

Monday’s trading session concluded with the index at 24,855 points, having spent nearly the entire day in positive territory and reaching an intraday peak of 24,923. The accompanying trading volume suggested conviction behind the move, rather than mere short-term speculation. However, the pre-market picture tells a different story.

Shares of Nvidia are sliding following reports of delays in H200 chip sales to China. For an index where chipmaking giants carry substantial weight, this news acts as a potent headwind. Futures are indicating a lower open, trading around 24,839 points, a decline of approximately 27 points. While this seems minor, it could signal a crucial shift in market sentiment.

Key Market Movers:

Should investors sell immediately? Or is it worth buying NASDAQ 100?

  • Supporting Acts: Alphabet is holding onto gains of over 2 percent from the previous session, while Broadcom remains in demand, fueled by ongoing optimism surrounding AI infrastructure.
  • Pressure Points: Nvidia’s weakness is weighing on the overall mood, and Tesla is concurrently battling to maintain its position around the symbolically important $400 mark.
  • Market Breadth: Yesterday’s trading was dominated by clear winners, but the landscape is now more mixed—a typical characteristic of consolidation phases.

Technical Landscape Holds the Key

From a technical perspective, the 24,800 level has become the focal point. Having acted as resistance yesterday, it now serves as potential support. A sustained break below this level could trigger a pullback toward Monday’s low of 24,455 points. If support holds, the path toward the 25,000 barrier remains open.

The Relative Strength Index (RSI) on an hourly chart indicates overbought conditions. However, the daily chart still shows room for further upward movement. This suggests a brief pause would be technically healthy, provided the overall bullish structure remains intact. The real danger may lie elsewhere—specifically, in the options market. A decisive break above 25,000 could potentially trigger a gamma squeeze, accelerating the rally once more.

The session’s direction will likely be determined by whether institutional investors choose to defend Monday’s gains or opt to take profits. With no major economic data releases scheduled, the mega-cap stocks will dictate the market’s trajectory. As long as Nvidia continues to show weakness, achieving a sustained breakthrough above 25,000 points appears challenging.

Ad

NASDAQ 100 Stock: Buy or Sell?! New NASDAQ 100 Analysis from February 7 delivers the answer:

The latest NASDAQ 100 figures speak for themselves: Urgent action needed for NASDAQ 100 investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

NASDAQ 100: Buy or sell? Read more here...

Tags: NASDAQ 100
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

OneSpan Stock
Cyber Security

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026
Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Next Post
Applovin Stock

Applovin Stock: Insider Selling Casts Shadow on Stellar Rally

Cintas Stock

Cintas Shares Face Divergent Analyst Views Amid Strong Performance

Super Micro Computer Stock

Super Micro Computer Faces Institutional Exodus Amid Earnings Disappointment

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com